Motivating Factors for Physician Ordering of Factor V Leiden Genetic Tests
Hindorff et al.
Arch Intern Med 2009;169:68-74.
ABSTRACT
| FULL TEXT
Physiological Interaction Between {alpha}-Adducin and WNK1-NEDD4L Pathways on Sodium-Related Blood Pressure Regulation
Manunta et al.
Hypertension 2008;52:366-372.
ABSTRACT
| FULL TEXT
{alpha}-Adducin Gly460Trp Variant Increases the Risk of Stroke in Hypertensive Dutch Women
Zafarmand et al.
Hypertension 2008;51:1665-1670.
ABSTRACT
| FULL TEXT
Role of rat {alpha} adducin in angiogenesis: Null effect of the F316Y polymorphism
Cappuzzello et al.
Cardiovasc Res 2007;75:608-617.
ABSTRACT
| FULL TEXT
Renin-Angiotensin System Haplotypes and the Risk of Myocardial Infarction and Stroke in Pharmacologically Treated Hypertensive Patients
Marciante et al.
Am J Epidemiol 2007;166:19-27.
ABSTRACT
| FULL TEXT
Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group
Arnett et al.
Circulation 2007;115:2878-2901.
ABSTRACT
| FULL TEXT
Cardiovascular Pharmacogenomics
Momary
Journal of Pharmacy Practice 2007;20:265-276.
ABSTRACT
Angiotensin-Converting Enzyme I/D and {alpha}-Adducin Gly460Trp Polymorphisms: From Angiotensin-Converting Enzyme Activity to Cardiovascular Outcome
Li et al.
Hypertension 2007;49:1291-1297.
ABSTRACT
| FULL TEXT
Logic Regression for Analysis of the Association between Genetic Variation in the Renin-Angiotensin System and Myocardial Infarction or Stroke
Kooperberg et al.
Am J Epidemiol 2007;165:334-343.
ABSTRACT
| FULL TEXT
{alpha}-Adducin Polymorphism, Atherosclerosis, and Cardiovascular and Cerebrovascular Risk
van Rijn et al.
Stroke 2006;37:2930-2934.
ABSTRACT
| FULL TEXT
Pharmacogenomics and Pharmacogenetics of Hypertension: Update and Perspectives--The Adducin Paradigm
Manunta and Bianchi
J. Am. Soc. Nephrol. 2006;17:S30-S35.
ABSTRACT
| FULL TEXT
Importance of Race/Ethnicity in Clinical Trials: Lessons From the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Taylor et al.
Circulation 2005;112:3654-3666.
FULL TEXT
Genetic variations of tubular sodium reabsorption leading to "primary" hypertension: from gene polymorphism to clinical symptoms
Bianchi
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005;289:R1536-R1549.
ABSTRACT
| FULL TEXT
Prospects for Personalized Cardiovascular Medicine: The Impact of Genomics
Ginsburg et al.
J Am Coll Cardiol 2005;46:1615-1627.
ABSTRACT
| FULL TEXT
Cardiovascular Risk in Relation to {alpha}-Adducin Gly460Trp Polymorphism and Systolic Pressure: A Prospective Population Study
Li et al.
Hypertension 2005;46:527-532.
ABSTRACT
| FULL TEXT
Challenges in Systematic Reviews That Evaluate Drug Efficacy or Effectiveness
Santaguida et al.
ANN INTERN MED 2005;142:1066-1072.
ABSTRACT
| FULL TEXT
Cardiovascular pharmacogenomics
Johnson and Cavallari
Exp Physiol 2005;90:283-289.
ABSTRACT
| FULL TEXT
Links Between Dietary Salt Intake, Renal Salt Handling, Blood Pressure, and Cardiovascular Diseases
Meneton et al.
Physiol. Rev. 2005;85:679-715.
ABSTRACT
| FULL TEXT
Adducin Polymorphism: Detection and Impact on Hypertension and Related Disorders
Bianchi et al.
Hypertension 2005;45:331-340.
ABSTRACT
| FULL TEXT
Hypertension-Linked Mutation in the Adducin {alpha}-Subunit Leads to Higher AP2-{micro}2 Phosphorylation and Impaired Na+,K+-ATPase Trafficking in Response to GPCR Signals and Intracellular Sodium
Efendiev et al.
Circ. Res. 2004;95:1100-1108.
ABSTRACT
| FULL TEXT
Clinically Translated Ischemic Stroke Genomics
Meschia
Stroke 2004;35:2735-2739.
ABSTRACT
| FULL TEXT
Atherosclerotic Vascular Disease Conference: Writing Group II: Risk Factors
Smith et al.
Circulation 2004;109:2613-2616.
FULL TEXT
Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study
Tobin et al.
Eur Heart J 2004;25:459-467.
ABSTRACT
| FULL TEXT
Low-Salt Diet and Diuretic Effect on Blood Pressure and Organ Damage
Manunta and Bianchi
J. Am. Soc. Nephrol. 2004;15:S43-46.
ABSTRACT
| FULL TEXT
Cardiology: the past, the present, and the future
Braunwald
J Am Coll Cardiol 2003;42:2031-2041.
FULL TEXT
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Chobanian et al.
Hypertension 2003;42:1206-1252.
ABSTRACT
| FULL TEXT
Susceptibility Genes for Hypertension and Renal Failure
Freedman
J. Am. Soc. Nephrol. 2003;14:S192-194.
ABSTRACT
| FULL TEXT
Genomics and Medicine: Distraction, Incremental Progress, or the Dawn of a New Age?
Cooper and Psaty
ANN INTERN MED 2003;138:576-580.
ABSTRACT
| FULL TEXT
Outcome beyond blood pressure control?
Staessen et al.
Eur Heart J 2003;24:504-514.
FULL TEXT
Cardiovascular Pharmacogenomics: Current Status, Future Prospects
Anderson et al.
J CARDIOVASC PHARMACOL THER 2003;8:71-83.
ABSTRACT
Primer on Medical Genomics Part VI: Genomics and Molecular Genetics in Clinical Practice
Ansell et al.
Mayo Clin Proc. 2003;78:307-317.
ABSTRACT
Pharmacogenomics -- Drug Disposition, Drug Targets, and Side Effects
Evans and McLeod
NEJM 2003;348:538-549.
FULL TEXT
Genetic Marker for Which Hypertensive Patients Benefit Most from Diuretics
Journal Watch Cardiology 2002;2002:3-3.
FULL TEXT
Pharmacogenomics in Endocrinology
Hockett et al.
J. Clin. Endocrinol. Metab. 2002;87:2495-2499.
FULL TEXT
Basic Science and Translational Research in JAMA
Fontanarosa and DeAngelis
JAMA 2002;287:1728-1728.
FULL TEXT